Physician

Andrew Timothy Kraftson, MD

According to 2025 Medicare claims, Andrew Kraftson, MD (NPI: 1457558116) practices endocrinology in the Ann Arbor, MI market, with the plurality of this provider's patient population coming from Washtenaw, MI. This provider's primary affiliated billing organization is REGENTS OF THE UNIVERSITY OF MICHIGAN (NPI: 1962432963; TIN: 386006309) and primary practice location at 48105-9484. Kraftson is affiliated with the POM ACO (ACO ID: A1297), participating under the MSSP model.

Kraftson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 170 traditional Medicare patients, billed 386 HCPCS/CPT codes, and received $20,574 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 1,221 prescription claims across 154 beneficiaries totaling $763,997 in drug costs, led by Ozempic (Semaglutide). DME data shows 164 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $32,736 to $20,574. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $283,658 to $763,997. For DME billing, reported payments moved sharply higher in recent years, from $1,988 to $53,544.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$24K$48K2015 Medicare payment: $32,736 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $34,230 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $48,138 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $32,638 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $26,519 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $24,403 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $26,825 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $20,642 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $25,268 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $20,574 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015223431$32,736
2016259448$34,230
2017306630$48,138
2018265472$32,638
2019260442$26,519
2020231402$24,403
2021233418$26,825
2022178317$20,642
2023205402$25,268
2024170386$20,574

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$547K$1.1M2015 Drug cost: $283,658 (USD; Tot_Drug_Cst)2016 Drug cost: $339,946 (USD; Tot_Drug_Cst)2017 Drug cost: $415,705 (USD; Tot_Drug_Cst)2018 Drug cost: $542,806 (USD; Tot_Drug_Cst)2019 Drug cost: $593,824 (USD; Tot_Drug_Cst)2020 Drug cost: $625,022 (USD; Tot_Drug_Cst)2021 Drug cost: $768,182 (USD; Tot_Drug_Cst)2022 Drug cost: $870,912 (USD; Tot_Drug_Cst)2023 Drug cost: $1,093,274 (USD; Tot_Drug_Cst)2024 Drug cost: $763,997 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201597735$283,658
2016114866$339,946
20171331,126$415,705
20181351,147$542,806
20191361,101$593,824
20201361,141$625,022
20211461,149$768,182
20221621,317$870,912
20231451,316$1,093,274
20241541,221$763,997

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$33K$67K2015 Medicare payment: $4,000 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $9,901 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $4,575 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $15,641 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $34,536 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $41,631 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $58,947 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $66,536 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $63,019 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $53,069 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201579199$4,000
201659180$9,901
201790152$4,575
201860176$15,641
201965268$34,536
202058294$41,631
202139347$58,947
202247385$66,536
202339329$63,019
202425164$53,069

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes2626$101
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more5160$65
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes57115$62
95251Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report2134$23
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's6373$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OzempicSemaglutide1518,354$256,265
MounjaroTirzepatide902,862$103,880
TrulicityDulaglutide873,053$98,951
ForteoTeriparatide12336$49,728
JardianceEmpagliflozin421,800$34,892

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4239Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of serviceN25113$48,788
A4224Supplies for maintenance of insulin infusion catheter, per weekNN/R17$2,834
A4225Supplies for external insulin infusion pump, syringe type cartridge, sterile, eachNN/R13$1,096
A4253Blood glucose test or reagent strips for home blood glucose monitor, per 50 stripsNN/R21$351

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Andrew Timothy Kraftson, MD?

Tedicare shows public-source Medicare data for Andrew Timothy Kraftson, MD (NPI 1457558116), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Timothy Kraftson, MD have ACO affiliation data?

Andrew Timothy Kraftson, MD is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297).

What billing organization is linked to Andrew Timothy Kraftson, MD?

Andrew Timothy Kraftson, MD is linked to REGENTS OF THE UNIVERSITY OF MICHIGAN (billing NPI 1962432963) in the available physician profile data.

Does Andrew Timothy Kraftson, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.